The present application relates to compounds of formula
wherein the definitions are as described herein. The present compounds are high potential NK-3 receptor antagonists that are useful for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
本申请涉及以下式子的化合物,其中定义如本文所述。这些化合物是高潜力的NK-3受体
拮抗剂,可用于治疗抑郁症、疼痛、精神病、帕
金森病、精神分裂症、焦虑症和注意力缺陷多动障碍(AD
HD)。